Our findings shed light on an interplay between nicotine, BDNF, and β-AR signaling in regulating lung cancer cell survival and chemoresistance, which could likely lead to the development of novel therapeutic strategies that target this regulatory network in the future. The gene discussed is BDNF; the disease is lung carcinoma.